Line 792: |
Line 792: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| '''Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1''' | | '''Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1''' |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Myelodysplastic/myeloproliferative neoplasms''' | | '''Myelodysplastic/myeloproliferative neoplasms''' |
Line 804: |
Line 802: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Myelodysplastic syndromes''' | | '''Myelodysplastic syndromes''' |
Line 820: |
Line 816: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Acute myeloid leukaemia (AML) and related precursor neoplasms''' | | '''Acute myeloid leukaemia (AML) and related precursor neoplasms''' |
Line 852: |
Line 847: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Acute leukaemias of ambiguous lineage''' | | '''Acute leukaemias of ambiguous lineage''' |
Line 866: |
Line 860: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Precursor lymphoid neoplasms''' | | '''Precursor lymphoid neoplasms''' |
Line 882: |
Line 875: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Mature B-cell neoplasms''' | | '''Mature B-cell neoplasms''' |
Line 927: |
Line 919: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Mature T- and NK-cell neoplasms''' | | '''Mature T- and NK-cell neoplasms''' |
Line 956: |
Line 947: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Hodgkin lymphoma''' | | '''Hodgkin lymphoma''' |
Line 968: |
Line 958: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Immunodeficiency-associated lymphoproliferative disorders''' | | '''Immunodeficiency-associated lymphoproliferative disorders''' |
Line 982: |
Line 971: |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
| '''Histiocytic and dendritic cell neoplasms''' | | '''Histiocytic and dendritic cell neoplasms''' |